NET PROFIT (x1000 EUR)
EMPLOYEES
MedSand AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
39
|
62
|
47 |
| EBITDA |
-127
|
-128
|
-113 |
| Total assets |
143
|
131
|
84 |
| Current assets |
71
|
42
|
29 |
| Current liabilities |
25
|
28
|
14 |
| Equity capital |
110
|
97
|
66 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
76.9%
|
74.0%
|
78.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
27.3%
|
47.3%
|
56.0% |
| Current ratio |
284.0%
|
150.0%
|
207.1% |
| Return on equity (ROE) |
35.5%
|
63.9%
|
71.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.